'Ridiculously long waits' at A&E causing patients to miss medicine doses
The Royal College of Emergency Medicine (RCEM) found that time critical medicines, such as insulin for people with diabetes, Parkinson's drugs, epilepsy medicines and blood clot medication, are not being delivered consistently across emergency departments.
If these drugs are delayed or missed, the patient can deteriorate and is at greater risk of complications or death.
While patients are advised to remember to bring their medications to A&E and to take them, there is also a responsibility on NHS staff to make sure this happens.
This problem has "risen to prominence" because of "the increasing number of our patients who are having to endure ridiculously long waits in our emergency departments", said RCEM president-elect, Dr Ian Higginson.
With many patients forced to wait "12, 24, 48 hours and even longer", Dr Higginson said it is "vital" that ensuring patients receive time critical medicine is "an issue associated with these waits".
'Missing doses of medication for illnesses such as Parkinson's or diabetes is not just inconvenient, it is dangerous; and missing multiple doses can have serious consequences," he added.
The new study focused on oral levodopa for Parkinson's and insulin for diabetes, as these are common in patients in A&E and must be given on time.
Finding from 136 emergency departments, who submitted date for more than 13,000 people in A&E on the two medications, found more than half were not identified as being on the medication within 30 minutes of their arrival.
In addition, 68% of doses were not administered within 30 minutes of the expected time.
The research is part of the college's clinical Quality Improvement Programme (QIP) which aims to improve the care of A&E patients.
Dr Higginson said that the first-year report does show improvements are being made across the country, this work must be "replicated in every emergency department" so that "no one fears not being able to access their medication while in our care".
Dr Jonny Acheson, an emergency medicine consultant with Parkinson's, who led the study, said there has been improvements but more needs to be done.
'The findings contained in this report should serve as a call to action for both emergency medicine staff, as well as patients reliant on time critical medications, to ensure no dose is ever missed in A&E,' he said.
'Everyone has a role to play – paramedics and emergency medicine staff need to ask patients what medications they take, and likewise, people with Parkinson's and insulin treated diabetes need to tell staff they take a TCM and take their meds with them if they have to visit an A&E.
'We are pleased that focusing on identifying these patients has led to improvement.
'However, the NHS must think about how they identify people taking these types of medication and how they are able to ensure they receive their doses on time, every time while they are in the emergency department.
'These medicines are critical to the quality of these patients lives and we have a duty of care to ensure that they receive them when they should.'
Recommendations made in the report included patients on time critical medication being identified early when attending A&E, and for systems to be in place to ensure timely administration of this medication, including self administration.
The report also says there should be a clear line of responsibility for staff.
The QIP team made recommendations, including that patients on TCM need to be identified early when they attend A&E to start the process of getting all doses.
Systems also need to be in place to ensure timely administration of TCM, including self-administration, and there should be a clear line of responsibility for staff.
An NHS spokesperson said: 'We welcome this report and will look closely at the findings, to ensure any patient in need of time critical medicine does not lose out when in A&E and receives the medication they need or support to self-administer as they would at home.
'As the report makes clear, it is welcome to see improvements thanks to the hard work of frontline staff but more generally we know A&E waiting times are far too long and our upcoming urgent and emergency care plan will set out how we aim to bring these down ahead of next winter.'
The Specialist Pharmacy Service (SPS), a team of pharmacy professionals commissioned by NHS England to provide guidance has issued advice on delayed or missed medication.
It says that "taking a medicine at the wrong time may reduce its efficacy", while taking subsequent doses too close together "may also increase the risk of side effects".
In the event that patients do accidentally miss a dose, the SPS advises they check the patient information leaflet supplied with their medicine for further guidance.
Alternitavely, you can find a copy on the electronic medicines compendium, the manufacturer's website, or the Medicines and Healthcare products Regulatory Agency (MHRA) website. The NHS website also contains a selection of medicine guides.
Each medication will have its own guidance, so it is important to check the instructions for the drugs perscribed to you, but the SPS has issued some more general advice:
Never take a double dose to make up for a forgotten dose, unless advised by a prescriber.
For most medicines, it is acceptable to take a dose up to two hours late.
You can usually ignore warnings about taking the medicine with or without meals, unless there's a significant risk of serious side-effects.
For patients who take their medicine once or twice a day who have missed a dose, they should take that missed dose as soon as remembered, as long as the next dose is not due within a few hours. After that they should continue taking the medicine as usual.
For patients who take more than two doses per day who have missed a dose, they should skip the missed dose and wait until the next dose is due. Then continue taking the medicine at the usual times.
Some medicines including antiseizure medications, insulin, oral contraceptives and Parkinson's disease medication carry a higher risk, meaning patients should follow specific guidance issued for these drugs.
You can find this guidance here on the SPS's website.
Read more
What are silverfish and are they harmful? Details of insects found in UK hospitals (BirminghamLive)
Give us more GP appointments, public tells Starmer (The Telegraph)
Almost one in five has received or witnessed 'corridor care', poll finds (PA Media)
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 hours ago
- Yahoo
Not just a garnish! The herb that can help shed water weight and relieve bloating
Parsley is often served as a garnish, alongside a roast chicken or on a steaming plate of spaghetti. But, with its rough texture and slightly bitter taste, many may not consider the herb to be a crucial part of their diet. Still, parsley is more than meets the eye, and experts say it can help to regulate your digestive health. 'It can help aid in digestion and help reduce bloating,' Amanda Capriglione, a registered dietitian, told The Healthy. 'It contains compounds that enable the expulsion of gas from the body.' Cultivated for thousands of years, the ancient Mediterranean plant is what is known as a natural diuretic. Diuretics are substances that help us to shed excess water weight and salt. Some others include dandelions, caffeine, and a variety of fruits and vegetables. A sprinkle of parsley in a tabouleh salad, green smoothie, or vegetable soup can be enough to make a difference. Just make sure it won't conflict with any medication you're on, and talk to your doctor if you're pregnant, as it could lead to abortion, according to past research. 'Incorporate herbs into your diet via a meal, not in a pill or liquid concentrated form,' Julia Zumpano, a registered dietitian, told the Cleveland Clinic. Parsley is also rich in flavones, which are a type of plant-based compounds that have anti-inflammatory benefits. Inflammation can result in autoimmune, neurodegenerative, gastrointestinal, and heart diseases, as well as certain cancers. Together, inflammatory diseases account for more than half of all deaths globally, according to the Clinic. Furthermore, the plant is high in antioxidants, which are substances — including vitamins — that can help to prevent or slow damage to our body's cells. Parsley contains vitamins C, A, and E, which can help reduce inflammation that could result in chronic disease. Eating parsley 'can help reduce the risk of arthritis, an inflammation of the joints,' Dr. Brunilda Nazario, the lead medical director for WebMD, told The Healthy. 'It is also an excellent source of flavonoids, antioxidants that help reduce the risk of many chronic diseases, including cancer, atherosclerosis, Alzheimer's, and Parkinson's disease.' If you're looking to fortify you bone health, parsley is also good source of vitamin K. Including vitamin K in your diet can do just that. Adult women need 90 micrograms of the vitamin a day, and men need 120, according to the National Institutes of Health. 'Ten sprigs of parsley is enough to reach your daily dose of vitamin K,' Capriglione said.


Medscape
9 hours ago
- Medscape
NICE Recommends Six Digital Platforms for Cardiac Rehab
The National Institute for Health and Care Excellence (NICE) has conditionally recommended six online platforms to support cardiac rehabilitation for adults with cardiovascular disease (CVD). The draft guidance allows the technologies to be used across the NHS for a 3-year trial period. Patients will be able to complete rehabilitation at home using smartphones, tablets, or computers. The platforms are Activate Your Heart, D REACH-HF, Digital Heart Manual, Gro Health HeartBuddy, KiActiv, and myHeart. They provide services such as exercise programmes, CVD education, dietary advice, medication management, and psychological support. Some also incorporate wearable devices to monitor activity levels. Addressing Low Participation Cardiac rehabilitation is a proven therapy that lowers the risk for repeat cardiac events and hospital readmissions. Yet, participation in traditional, in-person programmes remains low. In 2023, only 41% of eligible patients with acute coronary syndrome and 13% of those with heart failure in England took part. Digital platforms aim to improve access, particularly among groups with historically low participation rates. These include women, younger patients, ethnic minorities, and those unable to attend in-person sessions due to work, travel, or other commitments. Dr Anastasia Chalkidou, NICE's HealthTech programme director, said that the platforms 'offer real potential to transform how cardiac rehabilitation is offered to people to meet their individual circumstances,' adding that 'early data is promising and suggests, with safeguards in place, more people should now be given the opportunity to use these new technologies.' Evidence and Safeguards Clinical data are already available for several platforms. Activate Your Heart has been evaluated in three studies, including two randomised controlled trials (RCTs), while KiActiv has two studies, including one RCT, and myHeart has been assessed in two trials, including one RCT. Results suggest that digital rehabilitation can improve exercise capacity, cardiovascular risk profiles, and health-related quality of life. During the 3-year trial, evidence will be collected on clinical outcomes, uptake among diverse patient groups, cost-effectiveness, potential adverse events, and comparisons with standard rehabilitation. The conditional recommendation forms part of NICE's Early Value Assessment process. Following the trial, NICE will review the data and decide whether the technologies should be rolled out more widely across the NHS. NICE stressed that the recommended platforms should be used only after a full clinical assessment by a trained NHS professional to ensure they are suitable for each patient. Not all patients will be appropriate for digital rehabilitation, as barriers such as limited digital literacy and lack of access to devices may prevent some patients from taking part. Clinicians should also be aware that additional support may be needed for certain groups, including older adults, people with disabilities, those experiencing homelessness, and individuals for whom English is not a first language. Further Research Seven additional platforms — Beat Better, Datos Health, Get Ready, Luscii Vitals, Pumping Marvellous Cardiac Rehab Platform, R Plus Health, and Sword Move — require further research before routine NHS use. They should be offered only in research settings. A consultation on the draft recommendations is open until 3 September 2025, with comments invited via the NICE website.
Yahoo
10 hours ago
- Yahoo
Heart patients could now do their rehab remotely as ‘transformative' plans get NHS green light
People with heart problems will be able to complete rehabilitation online in their homes rather than waiting for face-to-face appointments. Experts said the programmes 'offer real potential to transform' how this type of care is delivered to individual patients. Six online platforms have been conditionally recommended to the NHS to support adults with cardiovascular disease (CVD) in new draft guidance from the National Institute for Health and Care Excellence (Nice). They are Activate Your Heart, D REACH-HF, Digital Heart Manual, Gro Health HeartBuddy, KiActiv and myHeart. CVD is a general term for conditions that impact the heart or blood vessels. It is estimated that it affects around seven million people in the UK. However, uptake for cardiac rehabilitation programmes, which can reduce the risk of further heart problems and hospital admissions, is low, according to Nice. Each platform is designed to offer cardiac rehabilitation online, including exercise programmes, advice on diet, medication management and psychological support. Some of the platforms also include wearable devices to monitor activity levels. Dr Anastasia Chalkidou, healthtech programme director at Nice, said: 'These digital platforms offer real potential to transform how cardiac rehabilitation is offered to people to meet their individual circumstances. 'We know that traditional programmes aren't reaching everyone who could benefit – particularly women, younger patients and people from ethnic minority backgrounds.' Before the online platforms are offered as an option, patients must be assessed by a healthcare professional. More support may be needed for older people, those with disabilities, homeless patients or those whose first language is not English, Nice suggests. The six platforms will be used on the NHS over the next three years to generate more evidence and data on their long-term effectiveness. Dr Chalkidou added: 'The early data is promising and suggests, with safeguards in place, more people should now be given the opportunity to use these new technologies. 'This three-year evidence collection period will give us the additional robust data we need to determine whether these innovations should be recommended as a permanent part of cardiac care.' A consultation on the conditional recommendation is now underway and will close on September 3. Seven other platforms – Beat Better, Datos Health, Get Ready, Luscii vitals, Pumping Marvellous Cardiac Rehab Platform, R Plus Health and Sword Move – require more research before they can be funded by the NHS, Nice said.